Published 1987 | Version v1
Report Open

Radiolabeled porphyrin versus gallium-67 citrate for the detection of human melanoma in athymic mice

Description

We performed the biodistribution and imaging studies of 111In and 67Ga labeled tetra(4-N-methylpyridyl) porphine, (T4NMPYP), and compared it to that of 67Ga citrate in athymic mice bearing a human melanoma xenograft. The biodistribution results of both 111In and 67Ga labeled T4NMPYP (3, 6, 24, and 48 hours) were similar but differed from that of 67Ga citrate (48 hours). The optimum tumor uptake of both radiolabeled porphyrins was at 6 hours postinjection and was lower than the tumor uptake of 67Ga citrate at 48 hours postinjection. Kidney was the only organ showing higher uptake of radiolabeled porphyrin compared to that of 67Ga citrate. The imaging studies performed with 111In T4NMPYP and 67Ga citrate correspond to the biodistribution results. Osteomyelitis present in one mouse showed good localization of 111In T4NMPYP. 15 refs., 3 figs., 5 tabs

Availability note (English)

MF available from INIS under the Report Number; Available from NTIS, PC A03/MF A01; 1 as DE88017251.

Files

20016002.pdf

Files (256.2 kB)

Name Size Download all
md5:aceef1b1fefdf677928f923b42794e6a
256.2 kB Preview Download

Additional details

Publishing Information

Imprint Pagination
18 p.
Report number
CONF-870613--1

Conference

Title
34. annual meeting of the Society of Nuclear Medicine.
Dates
2-5 Jun 1987.
Place
Toronto, Ontario (Canada).

Optional Information

Notes
Portions of this document are illegible in microfiche products.